Molecules and Cells

Cited by CrossRef (22)

  1. Francisco Javier García-Rodríguez, Carmen Martínez-Fernández, David Brena, Dmytro Kukhtar, Xènia Serrat, Ernest Nadal, Mike Boxem, Sebastian Honnen, Antonio Miranda–Vizuete, Alberto Villanueva, Julián Cerón. Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin. 2018
    https://doi.org/10.1242/dmm.033506
  2. Ahmed Hammad, Akhileshwar Namani, Mohamed Elshaer, Xiu Jun Wang, Xiuwen Tang. “NRF2 addiction” in lung cancer cells and its impact on cancer therapy. Cancer Letters 2019;467:40
    https://doi.org/10.1016/j.canlet.2019.09.016
  3. Akbar Minaei, Mehdi Sabzichi, Fatemeh Ramezani, Hamed Hamishehkar, Nasser Samadi. Co-delivery with nano-quercetin enhances doxorubicin-mediated cytotoxicity against MCF-7 cells. Mol Biol Rep 2016;43:99
    https://doi.org/10.1007/s11033-016-3942-x
  4. Xupeng Bai, Yibei Chen, Xiangyu Hou, Min Huang, Jing Jin. Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters. Drug Metabolism Reviews 2016;48:541
    https://doi.org/10.1080/03602532.2016.1197239
  5. Qingbin Cui, Jing-Quan Wang, Yehuda G. Assaraf, Liang Ren, Pranav Gupta, Liuya Wei, Charles R. Ashby, Dong-Hua Yang, Zhe-Sheng Chen. Modulating ROS to overcome multidrug resistance in cancer. Drug Resistance Updates 2018;41:1
    https://doi.org/10.1016/j.drup.2018.11.001
  6. Sepideh Mirzaei, Aliasghar Tabatabaei Mohammadi, Mohammad Hossein Gholami, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Kiavash Hushmandi, Pooyan Makvandi, Marek Samec, Alena Liskova, Peter Kubatka, Noushin Nabavi, Amir Reza Aref, Milad Ashrafizadeh, Haroon Khan, Masoud Najafi. Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance. Pharmacological Research 2021;167:105575
    https://doi.org/10.1016/j.phrs.2021.105575
  7. Chao-Yue Sun, Qian-Yu Zhang, Guang-Juan Zheng, Bing Feng. Phytochemicals: Current strategy to sensitize cancer cells to cisplatin. Biomedicine & Pharmacotherapy 2019;110:518
    https://doi.org/10.1016/j.biopha.2018.12.010
  8. Miriam Sánchez-Ortega, Ana Clara Carrera, Antonio Garrido. Role of NRF2 in Lung Cancer. Cells 2021;10:1879
    https://doi.org/10.3390/cells10081879
  9. Rachel Toth, Noel Warfel. Strange Bedfellows: Nuclear Factor, Erythroid 2-Like 2 (Nrf2) and Hypoxia-Inducible Factor 1 (HIF-1) in Tumor Hypoxia. Antioxidants 2017;6:27
    https://doi.org/10.3390/antiox6020027
  10. Zhi-Guo Zheng, Hong Xu, Sha-Sha Suo, Xiao-Li Xu, Mao-Wei Ni, Lin-Hui Gu, Wei Chen, Liang-Yan Wang, Ye Zhao, Bing Tian, Yue-Jin Hua. The Essential Role of H19 Contributing to Cisplatin Resistance by Regulating Glutathione Metabolism in High-Grade Serous Ovarian Cancer. Sci Rep 2016;6
    https://doi.org/10.1038/srep26093
  11. Ibrahim Turan, Selim Demir, Serap Ozer Yaman, Deniz Canbolat, Ahmet Mentese, Yuksel Aliyazicioglu. An Investigation of the Antiproliferative Effect of Rhododendron luteum Extract on Cervical Cancer (HeLa) Cells via Nrf2 Signaling Pathway. Nutrition and Cancer 2022;74:1882
    https://doi.org/10.1080/01635581.2021.1955287
  12. Zhuqing Huang, Guotao Yang, Tao Shen, Xiaoning Wang, Haizhen Li, Dongmei Ren. Dehydrobruceine B enhances the cisplatin-induced cytotoxicity through regulation of the mitochondrial apoptotic pathway in lung cancer A549 cells. Biomedicine & Pharmacotherapy 2017;89:623
    https://doi.org/10.1016/j.biopha.2017.02.055
  13. Yun Yang, Ziyin Tian, Rui Guo, Feng Ren. Nrf2 Inhibitor, Brusatol in Combination with Trastuzumab Exerts Synergistic Antitumor Activity in HER2-Positive Cancers by Inhibiting Nrf2/HO-1 and HER2-AKT/ERK1/2 Pathways. Oxidative Medicine and Cellular Longevity 2020;2020:1
    https://doi.org/10.1155/2020/9867595
  14. Yu Li, Hengyi Yan, Xiaoman Xu, Hongbo Liu, Cen Wu, Li Zhao. Erastin/sorafenib induces cisplatin‑resistant non‑small cell lung cancer cell ferroptosis through inhibition of the Nrf2/xCT pathway. Oncol Lett 2019
    https://doi.org/10.3892/ol.2019.11066
  15. Hitesh Kumar, Rachna M. Kumar, Devanjali Bhattacharjee, Preethi Somanna, Vikas Jain. Role of Nrf2 Signaling Cascade in Breast Cancer: Strategies and Treatment. Front. Pharmacol. 2022;13
    https://doi.org/10.3389/fphar.2022.720076
  16. T F Spracklen, A A Vorster, L Ramma, S Dalvie, R S Ramesar. Promoter region variation in NFE2L2 influences susceptibility to ototoxicity in patients exposed to high cumulative doses of cisplatin. Pharmacogenomics J 2017;17:515
    https://doi.org/10.1038/tpj.2016.52
  17. Chorlada Paiboonrungruang, Emily Simpson, Zhaohui Xiong, Caizhi Huang, Jianying Li, Yahui Li, Xiaoxin Chen. Development of targeted therapy of NRF2high esophageal squamous cell carcinoma. Cellular Signalling 2021;86:110105
    https://doi.org/10.1016/j.cellsig.2021.110105
  18. Si Qin, De-Xing Hou. The Biofunctions of Phytochemicals and Their Applications in Farm Animals: The Nrf2/Keap1 System as a Target. Engineering 2017;3:738
    https://doi.org/10.1016/J.ENG.2017.03.011
  19. Zahra Payandeh, Abbas Pirpour Tazehkand, Ghasem Barati, Farhad Pouremamali, Houman Kahroba, Behzad Baradaran, Nasser Samadi. Role of Nrf2 and mitochondria in cancer stem cells; in carcinogenesis, tumor progression, and chemoresistance. Biochimie 2020;179:32
    https://doi.org/10.1016/j.biochi.2020.09.014
  20. Ming-Xing Zhou, Guo-Hui Li, Xue-Yi Wu, Lin Sun, Yan-Ru Li, Wen-Jing Yang, Dong-Mei Ren, Xiao-Ning Wang, Lan Xiang, Hong-Xiang Lou, Tao Shen. (2S)-5,6,7,3′,4′-pentamethoxyflavanone, a citrus polymethoxyflavone ameliorates arsenic- and cigarette smoke extract-induced cytotoxicity via activating Nrf2-mediated defense system. Journal of Functional Foods 2019;54:337
    https://doi.org/10.1016/j.jff.2019.01.019
  21. Xinyue Deng, Nan Lin, Jiaying Fu, Long Xu, Haoge Luo, Yao Jin, Yanan Liu, Liankun Sun, Jing Su, Li Yang. The Nrf2/PGC1α Pathway Regulates Antioxidant and Proteasomal Activity to Alter Cisplatin Sensitivity in Ovarian Cancer. Oxidative Medicine and Cellular Longevity 2020;2020:1
    https://doi.org/10.1155/2020/4830418
  22. Jiayu Zhu, Huihui Wang, Feng Chen, Jingqi Fu, Yuanyuan Xu, Yongyong Hou, Henry H. Kou, Cheng Zhai, M. Bud Nelson, Qiang Zhang, Melvin E. Andersen, Jingbo Pi. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy. Free Radical Biology and Medicine 2016;99:544
    https://doi.org/10.1016/j.freeradbiomed.2016.09.010